IRIS
SALTARELLA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.183
AS - Asia 1.489
EU - Europa 1.094
SA - Sud America 364
AF - Africa 93
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.102
SG - Singapore 614
CN - Cina 303
BR - Brasile 290
IT - Italia 236
RU - Federazione Russa 197
SE - Svezia 153
HK - Hong Kong 152
VN - Vietnam 145
DE - Germania 111
FR - Francia 100
FI - Finlandia 85
GB - Regno Unito 70
IN - India 51
ID - Indonesia 44
CA - Canada 41
BD - Bangladesh 39
BE - Belgio 29
ZA - Sudafrica 26
AR - Argentina 24
CI - Costa d'Avorio 24
MX - Messico 22
PL - Polonia 22
IQ - Iraq 19
TR - Turchia 18
CO - Colombia 17
MA - Marocco 17
JP - Giappone 16
LT - Lituania 16
ES - Italia 13
SA - Arabia Saudita 11
VE - Venezuela 11
AT - Austria 10
JO - Giordania 10
NL - Olanda 9
PH - Filippine 9
UA - Ucraina 9
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
IE - Irlanda 6
PK - Pakistan 6
AZ - Azerbaigian 5
MY - Malesia 5
CH - Svizzera 4
IR - Iran 4
KE - Kenya 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
NI - Nicaragua 2
NP - Nepal 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BG - Bulgaria 1
CU - Cuba 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HT - Haiti 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
Totale 6.215
Salva come PNG Salva come JPEG
Città #
Ashburn 470
Singapore 354
San Jose 260
Fairfield 229
Chandler 219
Hong Kong 149
Woodbridge 147
Beijing 143
Nyköping 129
Seattle 116
Cambridge 106
Ann Arbor 104
New York 102
Wilmington 102
Houston 101
Los Angeles 85
Bari 74
Council Bluffs 69
Helsinki 67
Lauterbourg 51
Dallas 46
Ho Chi Minh City 45
Munich 37
Jakarta 36
Brooklyn 34
Santa Clara 32
Roxbury 31
São Paulo 31
Lawrence 30
Brussels 28
Hanoi 26
Nanjing 25
Abidjan 24
Dong Ket 23
Falkenstein 22
Frankfurt am Main 20
Moscow 20
Boardman 19
Chicago 19
London 19
Des Moines 17
Johannesburg 17
Tokyo 16
Buffalo 15
San Diego 15
Washington 15
Dearborn 14
Montreal 14
Orem 14
Stockholm 14
Grottaglie 13
Marseille 13
Rome 13
Warsaw 13
Denver 12
Inglewood 12
Phoenix 12
Salvador 12
The Dalles 12
Toronto 12
Chennai 11
Turku 11
Amman 10
Columbus 10
Curitiba 10
Rio de Janeiro 10
Paris 9
Atlanta 8
Baghdad 8
Jacksonville 8
Mexico City 8
Nuremberg 8
Poplar 8
Princeton 8
Vienna 8
Basingstoke 7
Guangzhou 7
Haiphong 7
Jiaxing 7
Manchester 7
Boston 6
Brasília 6
Dublin 6
Milan 6
San Francisco 6
Secaucus 6
Tashkent 6
Ankara 5
Bogotá 5
Erbil 5
Florence 5
Medellín 5
Riyadh 5
Sorocaba 5
Augusta 4
Baku 4
Dhaka 4
Grafing 4
Istanbul 4
Nairobi 4
Totale 4.190
Salva come PNG Salva come JPEG
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 220
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 210
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 186
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 183
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 182
Identify multiple myeloma stem cells: Utopia? 181
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 178
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 178
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 170
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 157
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 151
Bortezomib treatment modulates autophagy in multiple myeloma 150
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 147
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 144
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 142
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 138
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 137
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 137
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 134
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 133
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 132
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 128
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 126
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 126
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 122
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 119
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 116
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 113
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 113
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 112
Drug repurposing in skeletal muscle ion channelopathies 101
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 101
null 101
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 100
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 98
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 93
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 92
Antiangiogenic drugs as chemosensitizers in hematological tumors 92
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 88
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 84
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 84
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 82
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 81
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 80
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 79
Pharmacological therapy of non-dystrophic myotonias 79
The “angiogenic switch” from MGUS to MM: what about the Notch role? 76
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 73
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies? 72
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 67
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 67
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 65
NSAIDS AS MODULATORS OF CATION CHANNELS: FENAMATES REPURPOSING IN CHANNELOPATHIES 56
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 55
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 40
null 31
null 30
RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells 6
Totale 6.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 0 0 46
2021/2022282 20 21 3 11 9 18 18 16 23 22 40 81
2022/2023560 52 89 45 44 51 70 11 74 84 11 15 14
2023/2024305 15 34 18 23 48 114 8 7 5 7 8 18
2024/20251.318 47 24 63 64 90 115 239 156 48 67 155 250
2025/20262.748 394 124 170 265 333 200 348 87 371 289 135 32
Totale 6.538